QT dispersion and risk factors for sudden cardiac death in patients with hypertrophic cardiomyopathy

American Journal of Cardiology

Volumn 82, Issue 12, 1998, Pages 1514-1519

  Yi, Gang ^a   Elliott, Perry ^a   McKenna, William J ^a   Prasad, Krishna ^a   Sharma, Sanjay ^a   Guo, Xiao Hua ^a   John Camm, A ^a   Malik, Marek ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; DYSPNEA; ELECTROCARDIOGRAM; FEMALE; HEART DEATH; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QT INTERVAL; RISK FACTOR; SCHOOL CHILD;

ADOLESCENT; ADULT; AGED; CARDIOMYOPATHY, HYPERTROPHIC; CHILD; DEATH, SUDDEN, CARDIAC; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; HEART CONDUCTION SYSTEM; HUMANS; MALE; MIDDLE AGED; RISK FACTORS;

EID: 0032534976     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(98)00696-1     Document Type: Article

References (30)

1. Maron BJ, Savage DD, Wolfson JF, Epstein SE. Prognostic significance of 24-hour ambulatory monitoring in patients with hypertrophic cardiomyopathy: A prospective study. Am J Cardiol 1981;48:252-257.
2. McKenna WJ, Camm AJ. Sudden death in hypertrophic cardiomyopathy: assessment of patients at high risk. Circulation 1989;80:1489-1492.
3. McKenna WJ, Deanfield J, Faruqui A, England D, Oakley CM, Goodwin JF. Prognosis in hypertrophic cardiomyopathy: role of age, and clinical, electrocardiographic and h emodynamic features. Am J Cardiol 1981;47:532-538.
4. Maron BJ, Cecchi F, McKenna WJ. Risk factors and stratification for sudden cardiac death in patients with hypertrophic cardiomyopathy. Br Heart J 1994; 72:S13-18.
5. Fananapazir L, Chang AC, Epstein SE, McAreavey D. Prognostic determinants in hypertrophic cardiomyopathy. Prospective evaluation of a therapeutic strategy based on clinical, Holter, haemodynamic, and electrophysiological findings. Circulation 1992;86:730-740.
6. McKenna WJ, England D, Doi JL, Deanfield J, Oakley CM, Goodwin JF. Arrhythmia in hypertrophic cardiomyopathy. I. Influence on prognosis. Br Heart J 1981;46:168-172.
7. Frenneaux MP, Counihan PJ, Caforio ALP, Chikamori T, McKenna WJ. Abnormal blood pressure response during exercise in hypertrophic cardiomyopathy. Circulation 1990;82:1995-2002.
8. Sadoul N, Prasad K, Elliott P, Bannerjee S, Frenneaux M, McKenna WJ. Prospective prognostic assessment of blood pressure response during exercise in patients with hypertrophic cardiomyopathy. Circulation 1997;96:2987-2991.
9. Kuo CS, Munakata K, Reedy P, Surawicz B. Characteristics and possible mechanism of ventricular arrhythmia dependent on the dispersion of action potential duration. Circulation 1983;67:1356-1367.
10. Day CP, McComb JM, Campbell RWF. QT dispersion: an indication of arrhythmia risk in patients with long QT intervals. Br Heart J 1990;63:342-344.
11. Dritsas A, Sbarouni E, Gilligan D, Nihoyannopoulos P, Oakley CM. QT interval abnormalities in hypertrophic cardiomyopathy. Clin Cardiol 1992;15: 739-742.
12. Buja G, Miorelli M, Turrini P, Melacini P, Nava A. Comparison of QT dispersion in hypertrophic cardiomyopathy between patients with and without ventricular arrhythmias and sudden death. Am J Cardiol 1993;72:973-976.
13. Schwartz PJ, Wolf MD. QT interval prolongation as predictor of sudden death in patients with myocardial infarction. Circulation 1978;57:1074-1077.
14. Perkiömäki JS, Koistinen J, Yli-Mäyry S, Huikuri HV. Dispersion of QT interval in patients with and without susceptibility to ventricular tachyarrhythmias after previous myocardial infarction. J Am Coll Cardiol 1995;26:174-179.
15. Report of the 1995 World Health Organisation/International Society and Federation of Cardiology Task Force on the Definition and Classification of Cardiomyopathies. Circulation 1996;93:841-842.
16. McKenna WJ, Spirito P, Desnos M, Dubourg O, Komajda M. Experience from clinical genetics in hypertrophic cardiomyopathy: proposal for new diagnostic criteria in adult members of affected families. Heart 1997;77:130-132.
17. Day CP, McComb JM, Matthews J, Campbell RWF. Reduction in QT dispersion by sotalol following myocardial infarction. Eur Heart J 1991;12:423-427.
18. Cui G, Sen L, Sager P, Uppal P, Singh BN. Effects of amiodarone, sematilide, and sotalol on QT dispersion. Am J Cardiol 1994;74:896-900.
19. Grimm W, Steder U, Menz V, Hoffmann J, Maisch B. Effect of amiodarone on QT dispersion in the 12-lead standard electrocardiogram and its significance for subsequent arrhythmic events. Clin Cardiol 1997;20:107-110.
20. Xue Q, Reddy S. New algorithms for QT dispersion analysis. In Computers in Cardiology. Piscataway, NJ: IEEE Press, 1996;293-296.
21. Malik M, Camm AJ. Mystery of QTc interval dispersion. Am J Cardiol 1997;79:785-787.
22. Zaidi M, Robert A, Fesler R, Derwael C, Brohet C. Dispersion of ventricular repolarisation in hypertrophic cardiomyopathy. J Electrocardiol 1996;29(suppl): 89-94.
23. Watson R, Schwartz JL, Maron BJ, Tucker E, Rosing DR, Josephson ME. Inducible polymorphic ventricular tachycardia and ventricular fibrillation in a subgroup of patients with hypertrophic cardiomyopathy at high risk for sudden death. J Am Coll Cardiol 1987;10:761-764.
24. Saumarez R, Camm AJ, Panagos A, Gill JS, Stewart JT, de Beider MA, Simpson IA, McKenna WJ. Ventricular fibrillation in hypertrophic cardiomyopathy is associated with increased fraction of paced right ventricular electrograms. Circulation 1992;86:467-474.
25. Sporton SC, Taggart P, Sutton PM, Walker JM, Hardman SM. Acute ischaemia: a dynamic influence on QT dispersion. Lancet 1997;349:306-309.
26. Spirito P, Rapezzi C, Autore C, Bruzzi P, Bellone P, Ortolani P, Fragola PV, Chiarella F, Zoni-Berisso M, Branzi A, Cannata D, Magnani B, Vecchio C. Prognosis of asymptomatic patients with hypertrophic cardiomyopathy and non-sustained ventricular tachycardia. Circulation 1994;90:2743-2747.
27. Counihan PJ, Fei L, Bashir Y, Farrell TG, Haywood GA, McKenna WJ. Assessment of heart rate variability in hypertrophic cardiomyopathy. Association with clinical and prognostic features. Circulation 1993;88:1682-1690.
28. Saumarez R, Slade AKB, Grace AA, Sadoul N, Camm AJ, McKenna WJ. The significance of paced electrogram fractionation in hypertrophic cardiomyopathy: a prospective study. Circulation 1995;91:2762-2768.
29. Spirito P, Maron BJ. Relation between extent of left ventricular hypertrophy and occurrence of sudden cardiac death in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 1990;15:1521-1526.
30. Watkins H, McKenna WJ, Thierfelder L, Suk HJ, Anan R, O'Donoghue A, Spirito P, Matsumori A, Moravec CS, Seidman JG, Seidman CE. Mutations in the genes for cardiac troponin T and alpha-tropomyosin in hypertrophic cardiomyopathy. N Engl J Med 1995;332:1058-1064.